PDF herunterladen
Synlett 2008(8): 1129-1132  
DOI: 10.1055/s-2008-1072716
LETTER
© Georg Thieme Verlag Stuttgart · New York

An Efficient One-Pot Synthesis of 1H-Pyrazolo[1,2-b]phthalazine-5,10-dione Derivatives

Ramin Ghahremanzadeh, Ghazaleh Imani Shakibaei, Ayoob Bazgir*
Department of Chemistry, Shahid Beheshti University, P. O. Box 19396-4716, Tehran, Iran
e-Mail: a_bazgir@sbu.ac.ir;
Weitere Informationen

Publikationsverlauf

Received 21 January 2008
Publikationsdatum:
16. April 2008 (online)

    Lizenzen und Reprints Alle Artikel dieser Rubrik

Abstract

An efficient, three-component, one-pot condensation reaction between phthalhydrazide, aromatic aldehydes, and malononitrile or ethyl cyanoacetate for the synthesis of 1H-pyrazolo[1,2-b]phthalazine-5,10-dione derivatives in excellent yields is reported.

Key words

malononitrile - ethyl cyanoacetate - phthalhydrazide - pyrazolo[1,2-b]phthalazine-5-dione

    References and Notes

  • 1 Strecker A. Liebigs Ann. Chem.  1850,  75:  27 
    CrossrefGoogle Scholar
  • 2 Dömling A. Ugi I. Angew. Chem. Int. Ed.  2000,  39:  3168 
    CrossrefPubMedGoogle Scholar
  • 3 Kappe CO. Acc. Chem. Res.  2000,  33:  879 
    CrossrefPubMedGoogle Scholar
  • 4 Terrett NK. Bell AS. Brown D. Ellis P. Bioorg. Med. Chem. Lett.  1996,  6:  1819 
    CrossrefGoogle Scholar
  • 5 Elguero J. In Comprehensive Heterocyclic Chemistry II   Vol. 3:  Katritzky AR. Rees CW. Scriven EF. Elsevier; Oxford: 1996.  p.1-75  
    Google Scholar
  • 6 Singh SK. Reddy PG. Rao KS. Lohray BB. Misra P. Rajjak SA. Rao YK. Venkatewarlu A. Bioorg. Med. Chem. Lett.  2004,  14:  499 
    CrossrefGoogle Scholar
  • 7 Genin MJ. Biles C. Keiser BJ. Poppe SM. Swaney SM. Tarpley WG. Yagi Y. Romero DL. J. Med. Chem.  2000,  43:  1034 
    CrossrefGoogle Scholar
  • 8 Al’-Assar F. Zelenin KN. Lesiovskaya EE. Bezhan IP. Chakchir BA. Pharm. Chem. J.  2002,  36:  598 
    CrossrefGoogle Scholar
  • 9 Jain RP. Vederas JC. Bioorg. Med. Chem. Lett.  2004,  14:  3655 
    CrossrefGoogle Scholar
  • 10 Carling RW. Moore KW. Street LJ. Wild D. Isted C. Leeson PD. Thomas S. O’Conner D. McKernan RM. Quirk K. Cook SM. Atack JR. Waftord KA. Thompson SA. Dawson GR. Ferris P. Castro JL.
    J. Med. Chem.  2004,  47:  1807 
    CrossrefGoogle Scholar
  • 11 Grasso S. DeSarro G. Micale N. Zappala M. Puia G. Baraldi M. Demicheli C. J. Med. Chem.  2000,  43:  2851 
    CrossrefGoogle Scholar
  • 12 Nomoto Y. Obase H. Takai H. Teranishi M. Nakamura J. Kubo K. Chem. Pharm. Bull.  1990,  38:  2179 
    Google Scholar
  • 13 Watanabe N. Kabasawa Y. Takase Y. Matsukura M. Miyazaki K. Ishihara H. Kodama K. Adachi H. J. Med. Chem.  1998,  41:  3367 
    CrossrefPubMedGoogle Scholar
  • 14 Razvi M. Ramalingam T. Sattur PB. Indian J. Chem., Sect. B: Org. Chem. Incl. Med. Chem.  1989,  28:  695 
    Google Scholar
  • 15 Agarwal A. Chauhan PMS. Tetrahedron Lett.  2005,  46:  1345 
    CrossrefGoogle Scholar
  • 16 Wang X.-S. Zhang M.-M. Jiang H. Yao C.-S. Tu S.-J. Tetrahedron  2007,  63:  4439 
    CrossrefGoogle Scholar
  • 17 Maggi R. Ballini R. Sartori G. Sartorio R. Tetrahedron Lett.  2004,  45:  2297 
    CrossrefGoogle Scholar
  • 18 Magedov IV. Manpadi M. Evdokimov NM. Elias EM. Rozhkova E. Ogasavara MA. Bettale JD. Przheval’ski NM. Rogelj S. Kornienko A. Bioorg. Med. Chem. Lett.  2007,  17:  3872 
    CrossrefGoogle Scholar
  • 19 Wang X.-S. Shi D.-Q. Wei X.-Y. Zong Z.-M. J. Chem. Res.  2004,  679 
    Google Scholar
  • 20a Sayyafi M. Seyyedhamzeh M. Khavasi HR. Bazgir A. Tetrahedron  2008,  in press
    CrossrefGoogle Scholar
  • 20b Dabiri M. Arvin-Nezhad H. Bazgir A. Tetrahedron  2007,  63:  1770 
    CrossrefGoogle Scholar
  • 20c Dabiri M. Delbari AS. Bazgir A. Synlett  2007,  821 
    CrossrefGoogle Scholar
  • 20d Dabiri M. Delbari AS. Bazgir A. Heterocycles  2007,  71:  543 
    CrossrefGoogle Scholar
  • 20e Amini MM. Shaabani A. Bazgir A. Catal. Commun.  2006,  7:  843 
    CrossrefGoogle Scholar
  • 20f Bazgir A. Seyyedhamzeh M. Yasaei Z. Mirzaei P. Tetrahedron Lett.  2007,  48:  8790 
    CrossrefGoogle Scholar
21

Typical Procedure for the Preparation of 3-Amino-5,10-dihydro-5,10-dioxo-1-phenyl-1 H -pyrazolo[1,2- b ]phthalazin-2-carbonitrile (7a)
A mixture of malononitrile (1 mmol), phthalhydrazide (1 mmol), benzaldehyde (1 mmol), PTSA (0.3 mmol), and [bmim]Br (0.30 g) was heated at 100 °C for 3 h (TLC). After cooling, the reaction mixture was washed with H2O (15 mL) and residue recrystallized from MeOH to afford the pure product 7a. Yellow powder (94%); mp 276-278 °C. IR (KBr): νmax = 3359, 3190, 2197, 1690, 1658 cm-1. MS (EI, 70 eV): m/z (%) = 316 (20) [M+], 299 (42), 239 (100). 1H NMR (300 MHz, DMSO-d 6): δ = 6.13 (1 H, s, CH), 7.29-7.47 (5 H, m, ArH), 7.93-8.26 (4 H, m, ArH), 8.09 (2 H, s, NH2) ppm. 13C NMR (75 MHz, DMSO-d 6): δ = 62.4, 63.6, 116.1, 127.2, 127.3, 127.7, 128.7, 128.9, 129.2, 134.1, 135.1, 138.7, 151.2, 154.2, 157.1 ppm. Anal. Calcd (%) for C18H12N4O2: C, 68.35; H, 3.82; N, 17.71. Found: C, 68.41; H, 3.87; N, 17.78.

22

Selected Characterization Data
3-Amino-1-(2-chlorophenyl)-5,10-dihydro-5,10-dioxo-1 H -pyrazolo[1,2- b ]phthalazine-2-carbonitrile (7b)
Yellow powder (88%); mp 259-262 °C. IR (KBr): νmax = 3370, 3176, 2207, 1695, 1658 cm-1. MS (EI, 70 eV): m/z
(%) = 350 (17) [M+], 333 (44), 239 (100). 1H NMR (300 MHz, DMSO-d 6): δ = 6.46 (1 H, s, CH), 7.33-7.62 (4 H, m, ArH), 7.87-8.30 (4 H, m, ArH), 8.15 (2 H, s, NH2) ppm. 13C NMR (75 MHz, DMSO-d 6): δ = 60.2, 61.0, 116.2, 127.2, 127.8, 128.3, 128.8, 129.2, 130.2, 130.4, 131.7, 134.3, 135.2, 135.8, 151.6, 154.0, 157.1 ppm. Anal. Calcd (%) for C18H11ClN4O2: C, 61.64; H, 3.16; N, 15.97. Found: C, 61.57; H, 3.11; N, 15.91.
3-Amino-1-(4-chlorophenyl)-5,10-dihydro-5,10-dioxo-1 H -pyrazolo[1,2- b ]phthalazine-2-carbonitrile (7c)
Yellow powder (91%); mp 270-272 °C. IR (KBr): νmax = 3375, 3264, 2200, 1662, 1655 cm-1. MS (EI, 70 eV): m/z
(%) = 350 (8) [M+], 333 (27), 239 (100). 1H NMR (300 MHz, DMSO-d 6): δ = 6.15 (1 H, s, CH), 7.41-7.53 (4 H, m, ArH), 7.93-8.26 (4 H, m, ArH), 8.13 (2 H, s, NH2) ppm. 13C NMR (75 MHz, DMSO-d 6): δ = 61.3, 62.7, 116.4, 127.1, 127.7, 128.9, 129.3, 133.3, 134.2, 135.1, 137.9, 151.2, 154.1, 157.1 ppm. Anal. Calcd (%) for C18H11ClN4O2: C, 61.64; H, 3.16; N, 15.97. Found: C, 61.56; H, 3.09; N, 15.92.
Ethyl 3-Amino-5,10-dihydro-1-(3-nitrophenyl)-5,10-dioxo-1 H -pyrazolo[1,2- b ]phthalazine-2-carboxylate (7k)
Yellow powder (93%); mp 239-240 °C. IR (KBr): νmax = 3360, 3249, 1693, 1651, 1613 cm-1. MS (EI, 70 eV): m/z
(%) = 408 (23) [M+], 286 (100), 240 (40), 162 (85). 1H NMR (300 MHz, DMSO-d 6): δ = 0.99 (3 H, t, 3 J HH = 9.2 Hz, CH3), 3.94 (2 H, q, 3 J HH = 7.8 Hz, OCH2), 6.22 (1 H, s, CH), 7.56-8.30 (10 H, m, NH2 and ArH), 8.26-8.27 ppm. 13C NMR (75 MHz, DMSO-d 6): δ = 14.51, 59.19, 63.10, 81.12, 122.58, 123.12, 127.14, 127.69, 129.09, 129.49, 129.99, 134.17, 134.56, 135.05, 142.61, 147.95, 150.52, 153.93, 157.39, 164.31 ppm. Anal. Calcd (%) for C20H16N4O6: C, 58.82; H, 3.95; N, 13.72. Found: C, 58.88; H, 3.89; N, 13.66.
Ethyl 3-Amino-5,10-dihydro-1-(4-nitrophenyl )-5,10-dioxo-1 H -pyrazolo[1,2- b ]phthalazine-2-carboxylate (7l)
Yellow powder (95%); mp 241-243 °C. IR (KBr): νmax = 3386, 3210, 1694, 1655, 1630 cm-1. MS (EI, 70 eV): m/z
(%) = 408 (13) [M+], 286 (81), 240 (17), 162 (100). 1H NMR (300 MHz, DMSO-d 6): δ = 1.03 (3 H, t, 3 J HH = 6.8 Hz, CH3), 3.95 (2 H, q, 3 J HH = 6.7Hz, OCH2), 6.18 (1 H, s, CH), 7.73-8.29 (10 H, m, NH2 and ArH) ppm. 13C NMR (75 MHz, DMSO-d 6): δ = 14.61, 59.27, 63.04, 81.18, 123.59, 125.58, 127.16, 127.73, 129.02, 129.25, 133.04, 134.22, 135.12, 147.34, 147.77, 153.81, 157.32, 164.26 ppm. Anal. Calcd (%) for C20H16N4O6: C, 58.82; H, 3.95; N, 13.72. Found: C, 58.75; H, 3.90; N, 13.78.
Ethyl 3-Amino-5,10-dihydro-5,10-dioxo-1-p-tolyl-1 H -pyrazolo[1,2- b ]phthalazine-2-carboxylate (7m)
Yellow powder (73%); mp 204-206 °C. IR (KBr): νmax = 3447, 3333, 1706, 1658, 1624 cm-1. MS (EI, 70 eV): m/z
(%) = 377 (27) [M+], 286 (100), 240 (25), 162 (10). 1H NMR (300 MHz, DMSO-d 6): δ = 1.04 (3 H, t, 3 J HH = 8.9 Hz, CH3), 2.25 (3 H, s, CH3), 3.96 (2 H, q, 3 J HH = 9.0 Hz, OCH2), 6.04 (1 H, s, CH), 7.07-7.38 (4 H, m, ArH), 7.69 (2 H, br s, NH2), 7.92-8.27 (4 H, m, ArH). 13C NMR (75 MHz, DMSO-d 6):
δ = 14.66, 21.17, 59.12, 63.45, 82.17, 127.11, 127.71, 128.93, 129.18, 129.34, 134.05, 135.11, 137.23, 137.26, 150.13, 153.49, 157.22, 164.55. Anal. Calcd (%) for C21H19N3O4: C, 66.83; H, 5.07; N, 11.13. Found: C, 66.88; H, 5.01; N, 11.19.